Evidence map›Paper›PMID 34702762›Full record

ArticleImmunoHorizons2021

Type I IFN-Driven Immune Cell Dysregulation in Rat Autoimmune Diabetes.

Natasha Qaisar, Adediwura Arowosegbe, Alan G Derr, Alper Kucukural, Basanthi Satish, Riccardo Racicot, Zhiru Guo, Melanie I Trombly, Jennifer P Wang

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Natasha QaisarDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Adediwura ArowosegbeDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Alan G DerrDiabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA; and.ORCID 0000-0003-2935-0453
Alper KucukuralDepartment of Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA.
Basanthi SatishDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Riccardo RacicotDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Zhiru GuoDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.ORCID 0000-0003-0603-9961
Melanie I TromblyDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Jennifer P WangDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA; jennifer.wang@umassmed.edu.ORCID 0000-0002-2556-9100
University of Massachusetts Chan Medical School · US

Funding

Differential roles for type I interferon and inflammatory pathways in autoimmune diabetesR01AI139095 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WANG, JENNIFER P · 2018 to 2022
$3.0M
Innate mechanisms for virus-induced diabetesR01AI116920 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WANG, JENNIFER P · 2016 to 2019
$2.0M
NIAID NIH HHS R01 AI116920NIAID NIH HHS R01 AI139095
6 · The paper itself

Abstract

Type 1 diabetes is a chronic autoimmune disease, characterized by the immune-mediated destruction of insulin-producing β cells of pancreatic islets. Essential components of the innate immune antiviral response, including type I IFN and IFN receptor (IFNAR)-mediated signaling pathways, likely contribute to human type 1 diabetes susceptibility. We previously showed that LEW.1WR1

Indexed as

AnimalsAutoimmunityCD8-Positive T-LymphocytesChemotaxisDiabetes Mellitus, Type 1Disease Models, AnimalFemaleGene Expression RegulationHistocompatibility Antigens Class IIHumansInterferon Type IKiller Cells, NaturalMaleNeutrophilsParvoviridae InfectionsParvovirusHistocompatibility Antigens Class IIInterferon Type IReceptor, Interferon alpha-beta

Identifiers

PMID34702762
PMCPMC9109816
OpenAlexW3208007210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.